#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3388502	A	Pro-drug conversion in pH 7.4 PBS solution assessed as oncrasin-72 release at 0.5 mg/ml by HPLC method		1		assay format	Scientific Literature
2.	ALA3388503	A	Pro-drug conversion in pH 7.4 PBS solution assessed as complete oncrasin-72 release measured after 6 hrs at 0.5 mg/ml by HPLC method		1		assay format	Scientific Literature
3.	ALA3388504	A	Pro-drug conversion in human plasma assessed as oncrasin-72 release by HPLC method	Homo sapiens	1		cell-free format	Scientific Literature
4.	ALA3388505	F	Anticancer activity against human NCI-H157 cells at 0.03 to 30 uM by sulforhodamine B assay	Homo sapiens	2		cell-based format	Scientific Literature
5.	ALA3388506	F	Anticancer activity against human H460 cells at 0.03 to 30 uM by sulforhodamine B assay	Homo sapiens	2		cell-based format	Scientific Literature
6.	ALA3388507	F	Anticancer activity against human Calu3 cells at 0.03 to 30 uM by sulforhodamine B assay	Homo sapiens	2		cell-based format	Scientific Literature
7.	ALA3388508	F	Anticancer activity against human H1299 cells at 0.03 to 30 uM by sulforhodamine B assay	Homo sapiens	2		cell-based format	Scientific Literature
8.	ALA3388510	P	Stability in powder form in non-evacuated chambers at 37 degC after 1 to 14 days by HPLC method		2		small-molecule physicochemical format	Scientific Literature
9.	ALA3388511	P	Stability in powder form in non-evacuated chambers at room temperature by HPLC method		1		small-molecule physicochemical format	Scientific Literature
10.	ALA3388512	P	Stability in powder form in non-evacuated chambers at 4 degC by HPLC method		1		small-molecule physicochemical format	Scientific Literature
11.	ALA3388513	P	Stability in powder form in non-evacuated chambers at 37 degC by HPLC method		1		small-molecule physicochemical format	Scientific Literature
12.	ALA3388514	P	Stability in powder form in non-evacuated chambers at 37 degC after 90 days by HPLC method		1		small-molecule physicochemical format	Scientific Literature
13.	ALA3388516	P	Stability in stock solution with Solutol HS15 and ethyl alcohol solvent at room temperature by HPLC method		2		small-molecule physicochemical format	Scientific Literature
14.	ALA3389094	P	Stability in stock solution with Solutol HS15 and ethyl alcohol solvent at 4 degC by HPLC method		1		small-molecule physicochemical format	Scientific Literature
15.	ALA3389095	P	Stability in injectable solution with Solutol HS15 and ethyl alcohol and 0.9% NaCl assessed as drug hydrolysis within 7 hrs at room temperature by HPLC method		2		small-molecule physicochemical format	Scientific Literature
16.	ALA3389096	P	Stability in injectable solution with Solutol HS15 and ethyl alcohol and 0.9% NaCl assessed as drug hydrolysis within 7 hrs at 37 degC by HPLC method		2		small-molecule physicochemical format	Scientific Literature
17.	ALA3389097	A	Half life in Balb/c mouse at 25 mg/kg, iv using compound formulated in Solutol HS15 and ethyl alcohol by HPLC/MS method	Mus musculus	2		organism-based format	Scientific Literature
18.	ALA3389098	A	Half life in Balb/c mouse assessed as oncrasin-72 release at 25 mg/kg, iv using compound formulated in Solutol HS15 and ethyl alcohol by HPLC/MS method	Mus musculus	1		organism-based format	Scientific Literature
19.	ALA3390320	A	Drug level in liver of Balb/c mouse xenografted with human Calu3 cells assessed as aldehyde metabolite level at 60 mg/kg, iv using compound formulated in Solutol HS15 and ethyl alcohol measured after 24 hrs by HPLC/MS method	Mus musculus	2		organism-based format	Scientific Literature
20.	ALA3381200	A	Drug level in lung of Balb/c mouse xenografted with human Calu3 cells assessed as aldehyde metabolite level at 60 mg/kg, iv using compound formulated in Solutol HS15 and ethyl alcohol measured after 24 hrs by HPLC/MS method	Mus musculus	2		organism-based format	Scientific Literature